Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-27 @ 11:11 PM
Study NCT ID:
NCT00416494
Status:
COMPLETED
Last Update Posted:
2014-09-03
First Post:
2006-12-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Sponsor:
Herbert Hurwitz, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00008646
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |